Streetbeat News

DOC

Healthpeak Properties, Inc.

https://www.healthpeak.com

Industry

REIT - Healthcare Facilities

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Open

20.60

Mkt cap

15B

Volume

2.1M

High

21.12

P/E Ratio

42.59

52-wk high

23.26

Low

20.50

Div yield

0.07

52-wk low

16.02

Healthpeak Properties, Inc. has extended its $3 billion revolving credit facility and made amendments to its term loans, indicating strong lender support.

Portfolio Pulse from

December 09, 2024 | 9:30 pm

The article discusses the risks of investing in high-yield REITs, specifically highlighting the issues with Sachem Capital Corp. and Healthcare Realty Trust Incorporated. Sachem Capital has a history of dividend cuts and poor financial performance, while Healthcare Realty Trust faces management instability and unsustainable dividends.

Portfolio Pulse from

November 23, 2024 | 12:15 pm

Healthpeak Properties, a U.S. healthcare-focused REIT, has raised its annual forecast for funds from operations due to strong demand for its medical office properties.

Portfolio Pulse from

November 18, 2024 | 10:15 pm

Baird analyst Amanda Sweitzer has maintained an Outperform rating on Healthpeak Properties and raised the price target from $24 to $25.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 11:52 am

Healthpeak Properties has revised its FY24 FFO as adjusted per share guidance from $1.77-$1.81 to $1.79-$1.81 and its AFFO per share from $1.54-$1.58 to $1.56-$1.58.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 8:23 pm

Healthpeak Properties reported its Q3 2024 financial results, showing an increase in AFFO per share to $0.41 from $0.40 the previous year, and total revenues rising to $700.4 million from $556.24 million.

Portfolio Pulse from Benzinga Newsdesk

October 24, 2024 | 8:20 pm

Healthpeak Properties (NYSE:DOC) has received a range of analyst ratings over the past three months, with a recent increase in the average 12-month price target to $24.75. Analysts have raised their ratings and price targets, reflecting positive sentiment. Healthpeak's financial performance is strong, with significant revenue growth and profitability metrics surpassing industry averages.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 8:00 pm

In the past three months, 8 analysts have rated Healthpeak Properties (NYSE:DOC), with a mix of bullish and somewhat bullish sentiments. The average 12-month price target has increased by 11.24% to $24.75. Analysts have raised their ratings and price targets, reflecting positive market dynamics and company performance. Healthpeak Properties has shown strong financial health with significant revenue growth, high net margin, and efficient debt management.

Portfolio Pulse from Benzinga Insights

October 21, 2024 | 4:00 pm

Deutsche Bank has upgraded Healthpeak Properties from Hold to Buy, increasing the price target from $20 to $28.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 11:37 am

In the past three months, analysts have shown a positive shift in sentiment towards Healthpeak Properties (NYSE:DOC), with several raising their price targets. The average 12-month price target increased by 8.07% to $24.5. Healthpeak Properties has demonstrated strong financial performance, with significant revenue growth and profitability metrics exceeding industry averages.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 4:00 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.